- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03080285
Efficacy of Over-glasses Patch Treatment for Amblyopia in Children : OPTA Study (OPTA)
Efficacy of Over-glasses Patch Treatment for Amblyopia in Children :OPTA Study, A Prospective Randomized Clinical Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- moderate amblyopia (logMAR visual acuity in the amblyopic eye 0.3 to 0.7 inclusive)
- logMAR visual acuity in the sound eye of 0.1 or better
- intereye acuity difference of larger or equal to 0.3 of logMAR visual acuity
- the presence of or a history of an amblyogenic factor meeting study-specified criteria for strabismus and/or anisometropia.
Exclusion Criteria:
- presence of an ocular cause for low vision
- myopia greater than -6.0 diopters (D) spherical equivalent in either eye
- prior intraocular or refractive surgery
- treatment for amblyopia (other than spectacle correction) within the 6 months prior to the enrollment
- Down syndrome
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Conventional patch
The patients were prescribed 2 hours of patching per day for the sound eye and the spectacles were to be worn full-time. Conventional patch is occlusion treatment sticker (Opticlude Eye Patch, 3M, Maplewood, MN, USA) with an adhesive material attached to the skin and serves to cover the eyes. |
Conventional patch (Opticlude Eye Patch, 3M, Maplewood, MN, USA) is applied to the patients.
They were prescribed 2 hours of patching per day for the sound eye.
|
Experimental: over-glasses patch
the patients were prescribed 2 hours of patching per day for the sound eye and the spectacles were to be worn full-time. Over-glasses patch (Tomato Eye Patch, Tomato Inc., Busan, South Korea) is made of fabric and covers the glasses, hence serves to cover the eyes. |
Over-glasses patch (Tomato Eye Patch, Tomato Inc., Busan, South Korea) is applied to the patients.
They were prescribed 2 hours of patching per day for the sound eye.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in visual acuity (logMAR)
Time Frame: 17 weeks
|
changes in best- corrected visual acuity between before treatment and after 17 weeks. Visual acuity is assessed using the Snellen chart. logMAR visual acuity ranges 0.0 to 3.0. logMAR visual acuity of 0.0 corresponds to 20/20. Lower scores represents better functioning. |
17 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
amblyopia treatment index
Time Frame: 17 weeks
|
A modified version of ATI was provided to the parent(s) of all the enrolled minor patients as part of their follow-up visit with their child.
The test consisted of 20 items, translated to Korean by one English language specialist and three ophthalmologists.
The score from each question contributed to a sub-scale of the adverse effect (question numbers 2, 3, 4, 7, 8, 9, 13, and 16), compliance (question numbers 1, 5, 6a, 10 and 12), and social stigma (question numbers 11, 14 and 18).
The questionnaires were scored on a 5-point Likert scale system, and the parent-provided questionnaire used a strength of agreement scale with responses of "strongly agree" (5), "agree" (4), "neither agree nor disagree" (3), "disagree" (2), "strongly disagree" (1), and "not applicable."
In the test, the majority of items were negative statements, and therefore, a higher score indicated a higher negative impact or a higher burden.
Reverse scoring was applied to the few items that were positive statements.
|
17 weeks
|
the best corrected visual acuity
Time Frame: 17 weeks
|
best corrected visual acuity (logMAR) at 17 weeks Visual acuity is assessed using the Snellen chart.
logMAR visual acuity ranges 0.0 to 3.0.
logMAR visual acuity of 0.0 corresponds to 20/20.
Lower scores represents better functioning.
|
17 weeks
|
change of binocularity
Time Frame: 17 weeks
|
A binocularity index was determined with the use of the Worth 4 Dot test at near and the Titmus stereo test with a scale ranging from 0 to 4 with the following characteristics: 0, indicating complete suppression; 1, a moderate central suppression scotoma with peripheral fusion at near only indicated by fusion on the Worth 4 Dot test at near; 2, a small suppression scotoma and peripheral fusion indicated by fusion of the Titmus stereo fly; 3, moderate stereoacuity (100-400 arc seconds) on the stereo test animals (1 to 3 animals) and/or on the stereo test circles (1 to 5 circles); and 4, good stereoacuity (<80 arc seconds ) on the stereo test circles (6 to 9 circles).
|
17 weeks
|
Collaborators and Investigators
Investigators
- Study Chair: Hee young Choi, MD, PhD, Pusan National University hospotal
Publications and helpful links
General Publications
- Scheiman MM, Hertle RW, Beck RW, Edwards AR, Birch E, Cotter SA, Crouch ER Jr, Cruz OA, Davitt BV, Donahue S, Holmes JM, Lyon DW, Repka MX, Sala NA, Silbert DI, Suh DW, Tamkins SM; Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol. 2005 Apr;123(4):437-47. doi: 10.1001/archopht.123.4.437.
- Flynn JT, Schiffman J, Feuer W, Corona A. The therapy of amblyopia: an analysis of the results of amblyopia therapy utilizing the pooled data of published studies. Trans Am Ophthalmol Soc. 1998;96:431-50; discussion 450-3.
- Wallace MP, Stewart CE, Moseley MJ, Stephens DA, Fielder AR; Monitored Occlusion Treatment Amblyopia Study (MOTAS) Cooperatives; Randomized Occlusion Treatment Amblyopia Study (ROTAS) Cooperatives. Compliance with occlusion therapy for childhood amblyopia. Invest Ophthalmol Vis Sci. 2013 Sep 17;54(9):6158-66. doi: 10.1167/iovs.13-11861.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1404-021-017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Amblyopia
-
Universitat Politècnica de CatalunyaParc Sanitari Sant Joan de Déu; Hospital Mutua de TerrassaCompletedAmblyopia | Anisometropic Amblyopia | Strabismic Amblyopia | Amblyopia Occlusion | Unilateral AmblyopiaSpain
-
Vedea Healthware BVElisabeth-TweeSteden Ziekenhuis; Jeroen Bosch Ziekenhuis; Health Holland; Oogziekenhuis... and other collaboratorsRecruitingAmblyopia | Amblyopia, Anisometropic | Amblyopia StrabismicNetherlands
-
Universitat Politècnica de CatalunyaHospital Mutua de TerrassaCompletedAmblyopia | Anisometropic Amblyopia | Strabismic AmblyopiaSpain
-
Alaska Blind Child DiscoveryCompletedStrabismus | Strabismic Amblyopia | Refractive AmblyopiaUnited States
-
Baylor College of MedicineActive, not recruitingHyperopia | High Myopia | Anisometropia | Amblyopia Isometropic | Amblyopia Bilateral | High AstigmatismUnited States
-
Medical University of ViennaRecruitingAmblyopia ex Strabismus | Amblyopia ex AnisometropiaAustria
-
National Cheng-Kung University HospitalChang Gung Memorial HospitalCompletedAmblyopia | Amblyopia, Anisometropic
-
Shahid Beheshti University of Medical SciencesUnknownThe New Treatment in Amblyopia TherapyIran, Islamic Republic of
-
University of BaselUniversity Medical Center NijmegenWithdrawnStrabismic Amblyopia
-
Wenzhou Medical UniversityUnknown
Clinical Trials on Conventional patch
-
University of California, San DiegoCompletedStroke | Brain Diseases | Brain Injuries | Vasospasm | Medical Device ComplicationUnited States
-
Universitaire Ziekenhuizen KU LeuvenBEDAL; RemedusTerminatedNeoplasms | Cystic Fibrosis | Pulmonary HypertensionBelgium
-
Abdel Kadar ClinicCompleted
-
Shahid Beheshti University of Medical SciencesUnknownGlaucomaIran, Islamic Republic of
-
Children's National Research InstituteEnrolling by invitationSyncope | Cardiac ArrhythmiaUnited States
-
Coloplast A/SCompleted
-
En Chu Kong HospitalCompleted
-
Coloplast A/SCompleted
-
University of ZurichCompletedAllergic RhinoconjunctivitisSwitzerland